Quick Takeaways
- Dellora Investments LP filed SCHEDULE 13G/A for TENAX THERAPEUTICS, INC. Common Stock, $0.0001 par value per share (TENX).
- Disclosed ownership: 10%.
- Date of event: 08 Jan 2025.
Dellora Investments LP - 08 Jan 2025 SCHEDULE 13G/A Report for TENAX THERAPEUTICS, INC. Common Stock, $0.0001 par value per share (TENX)
- Filing Manager
- Dellora Investments LP
- Reporting Manager
- Dellora Investments LP
- Symbol
- TENX
- Shares outstanding
- 3,408,456 shares
- Disclosed Ownership
- 351,071 shares
- Ownership
- 10%
- Form type
- SCHEDULE 13G/A
- Filing time
- 15 Jan 2025, 16:14:20 UTC
- Date of event
- 08 Jan 2025
- Previous filing
- 05 Dec 2024
- Next filing
- 04 Apr 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Dellora Investments LP disclosed 10% ownership in TENAX THERAPEUTICS, INC. Common Stock, $0.0001 par value per share (TENX) on 08 Jan 2025."
What Changed
- Previous schedule filing date: 05 Dec 2024.
- Current filing was accepted on 15 Jan 2025, 16:14.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Dellora Investments Master Fund LP | 9% | 305,257 | 0 | 305,257 | /s/ Kevin Pyun | Principal, Dellora Investments Fund GP LLC, its General Partner | |
| Dellora Investments LP | 10% | 351,071 | 0 | 351,071 | /s/ Kevin Pyun | Principal, Dellora Investments GP LLC, its General Partner | |
| Kevin Pyun | 10% | 351,071 | 0 | 351,071 | /s/ Kevin Pyun | Kevin Pyun |